Skinner M A, Swain M, Simmons R, McCarty K S, Sullivan D C, Iglehart J D
Department of General and Thoracic Surgery, Duke University Medical Center, Durham, NC 27710.
Ann Surg. 1988 Aug;208(2):203-8. doi: 10.1097/00000658-198808000-00012.
Several studies have demonstrated that mammographic screening of asymptomatic women results in a lower mortality rate where breast cancer is concerned. Often, screening mammograms reveal a nonpalpable radiographic abnormality and the diagnosis must be determined by an excisional biopsy after radiographic needle localization. The mammographic features associated with 179 nonpalpable breast abnormalities biopsied after radiographic needle localization were carefully characterized. There were 41 carcinomas (23%) in the series. The aim of this study was to determine which radiographic findings, if any, strongly portend the presence of either a malignant or benign lesion. Mammographic features that were commonly associated with malignancy include a change from a previous mammogram, a distortion of the surrounding architecture, the association of a soft tissue density and calcifications, and the presence of more than ten calcifications in the lesion. The radiographic abnormalities which were more commonly associated with benign disease include well-defined densities without calcifications, asymmetric densities without calcifications, and abnormalities consisting solely of a focus of mammographic calcifications that have fewer than ten concretions. The incidence of malignancy in lesions having these mammographic characteristics was only 5.5%. On the basis of these results alone, no firm threshold for biopsy can be recommended. The risks of deferring biopsy until there is worsening of the mammographic image remains to be determined.
多项研究表明,对无症状女性进行乳腺钼靶筛查可降低乳腺癌相关的死亡率。通常,筛查性乳腺钼靶会发现不可触及的影像学异常,诊断必须通过影像学引导下的针定位切除活检来确定。对179例影像学引导下针定位活检的不可触及乳腺异常的钼靶特征进行了仔细描述。该系列中有41例癌(23%)。本研究的目的是确定哪些影像学表现(如果有的话)强烈预示恶性或良性病变的存在。通常与恶性肿瘤相关的钼靶特征包括与先前钼靶相比的变化、周围结构的扭曲、软组织密度与钙化的关联以及病变中存在十多个钙化。更常与良性疾病相关的影像学异常包括无钙化的边界清晰的密度影、无钙化的不对称密度影以及仅由少于十个钙化点组成的钼靶钙化灶。具有这些钼靶特征的病变中恶性肿瘤的发生率仅为5.5%。仅基于这些结果,无法推荐明确的活检阈值。推迟活检直至钼靶图像恶化的风险仍有待确定。